Lippincott, Williams & Wilkins, Current Opinion in Allergy and Clinical Immunology, 5(9), p. 454-465, 2009
DOI: 10.1097/aci.0b013e3283303ebb
Full text: Unavailable
Multiple action drugs, such as azelastine, epinastine, ketotifen and olopatadine, have recently been suggested to combine antihistaminic effect, mast cell stabilization and anti-inflammatory action. This pharmaceutical class is, therefore, rapidly becoming the first choice for prevention and treatment for allergic conjunctivitis.